Company profile for Candel Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Candel Therapeutics is a Boston-area privately held biopharmaceutical company. We are committed to saving, extending and improving the lives of cancer patients and their families through the development and commercialization of innovative and personalized cancer immunotherapies. At the forefront of these efforts is our proprietary Gene Mediated Cytotoxic Immunotherapy™ (GMCI™), a platform technology designed to stimulate a...
Candel Therapeutics is a Boston-area privately held biopharmaceutical company. We are committed to saving, extending and improving the lives of cancer patients and their families through the development and commercialization of innovative and personalized cancer immunotherapies. At the forefront of these efforts is our proprietary Gene Mediated Cytotoxic Immunotherapy™ (GMCI™), a platform technology designed to stimulate a patient’s immune system to naturally fight against his or her cancer. GMCI™ is a novel and versatile technology that can be applied to a variety of solid tumors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
117 Kendrick Street, Suite 450 Needham, Massachusetts 02494
Telephone
Telephone
6179165445
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/17/3189579/0/en/Candel-Therapeutics-to-Host-Virtual-R-D-Event-on-December-5-2025.html

GLOBENEWSWIRE
17 Nov 2025

https://www.fiercebiotech.com/biotech/century-candel-and-macrogenics-call-time-certain-clinical-trials-conserve-cash

FIERCE BIOTECH
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187333/0/en/Candel-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Recent-Corporate-Highlights.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180386/0/en/Candel-Therapeutics-Showcases-Immunotherapy-Leadership-at-SITC-2025-Demonstrating-Integration-of-Clinical-Innovation-Multi-Omics-and-Artificial-Intelligence-to-Advance-Next-Generat.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179246/0/en/Candel-Therapeutics-to-Present-at-Jefferies-Global-Healthcare-Conference-in-London.html

GLOBENEWSWIRE
03 Nov 2025

https://www.globenewswire.com/news-release/2025/10/16/3167885/0/en/Candel-Therapeutics-Appoints-Leading-Systems-Immunology-Expert-Bali-Pulendran-Ph-D-to-Research-Advisory-Board.html

GLOBENEWSWIRE
16 Oct 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty